Doi.org/10.1002/cncr.21658
Jump to navigation
Jump to search
Target Article[edit | edit source]
Retraction: Behr TM, Griesinger F, Riggert J, et al. High-dose myeloablative radioimmunotherapy of mantle cell non-hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support: results of a pilot study. Ca; Behr TM, Griesinger F, Riggert J, et al.; NULL; 2005-12-15; https://doi.org/10.1002/cncr.21658
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.